Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Sales | 4,409 | 5 | 9,340 | 7,081 | 0 |
| Cost of Goods | 1,883 | 10 | 4,230 | 3,725 | N/A |
| Gross Profit | 2,525 | -5 | 5,110 | 3,356 | N/A |
| Operating Expenses | 8,665 | 300 | 4,560 | 3,405 | 1,190 |
| Operating Income | -5,875 | -295 | 780 | 676 | -1,190 |
| Interest Expense | 0 | 0 | 310 | 700 | -110 |
| Other Income | 311 | 5 | -260 | -256 | 480 |
| Pre-tax Income | -5,564 | -290 | 210 | -280 | -600 |
| Income Tax | -1,751 | -60 | 90 | -150 | 0 |
| Net Income Continuous | -3,813 | -1 | 120 | -130 | -600 |
| Net Income Discontinuous | N/A | 160 | 0 | N/A | N/A |
| Net Income | $-3,813 | $-10 | $110 | $-130 | $-600 |
| EPS Basic Total Ops | -93.00 | -1.00 | 3.77 | -4.46 | N/A |
| EPS Basic Continuous Ops | -117.50 | -0.03 | 4.12 | -4.46 | N/A |
| EPS Basic Discontinuous Ops | N/A | 5.48 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -93.00 | 4.00 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -117.50 | -0.03 | N/A | N/A | N/A |
| EPS Diluted Discontinuous Ops | N/A | 5.48 | N/A | N/A | N/A |
| EBITDA(a) | $-4,864 | $1,085 | $2,090 | $676 | $-830 |